A. Filppula

M. Niemi, J. Backman, M. Neuvonen, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation

M. Niemi, J. Backman, Anne M. Filppula, 2019, Clinical pharmacology and therapeutics.

Validation and development of MTH1 inhibitors for treatment of cancer.

Y. Kallberg, P. Artursson, R. Zubarev, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

In Vitro Assessment of Time-Dependent Inhibitory Effects on CYP2C8 and CYP3A Activity by Fourteen Protein Kinase Inhibitors

P. Neuvonen, J. Backman, Anne M. Filppula, 2014, Drug Metabolism and Disposition.

Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins

M. Niemi, M. Neuvonen, Feng Deng, 2021, Drug Metabolism and Disposition.

Comparative Hepatic and Intestinal Efflux Transport of Statins

M. Niemi, M. Neuvonen, S. Oswald, 2021, Drug Metabolism and Disposition.

Gemfibrozil Markedly Increases the Plasma Concentrations of Montelukast: A Previously Unrecognized Role for CYP2C8 in the Metabolism of Montelukast

M. Niemi, P. Neuvonen, T. Karonen, 2010, Clinical pharmacology and therapeutics.

Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations

P. Artursson, A. Mateus, P. Baranczewski, 2019, Scientific Reports.

Reevaluation of the Microsomal Metabolism of Montelukast: Major Contribution by CYP2C8 at Clinically Relevant Concentrations

Janne T. Backman, P. Neuvonen, J. Backman, 2011, Drug Metabolism and Disposition.

Translational aspects of cytochrome P450‐mediated drug–drug interactions: A case study with clopidogrel

J. Backman, Anne M. Filppula, A. Tornio, 2021, Basic & clinical pharmacology & toxicology.

Title Page In Vitro Assessment of Time-Dependent Inhibitory Effects on CYP 2 C 8 and CYP 3 A Activity by Fourteen Protein Kinase Inhibitors

P. Neuvonen, J. Backman, Anne M. Filppula, 2014 .

Clopidogrel but Not Prasugrel Significantly Inhibits the CYP2C8‐Mediated Metabolism of Montelukast in Humans

P. Neuvonen, M. Niemi, J. Backman, 2017, Clinical pharmacology and therapeutics.

Fabricating biomimetic materials with ice‐templating for biomedical applications

Li Wang, Yunru Yu, Lu Fan, 2023, Smart Medicine.

Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations

P. Artursson, A. Mateus, Anne M. Filppula, 2019, Scientific Reports.

Hydroxychloroquine is metabolized by CYP2D6, CYP3A4, and CYP2C8, and inhibits CYP2D6, while its metabolites also inhibit CYP3A in vitro.

M. Niemi, J. Backman, A. Filppula, 2022, Drug metabolism and disposition: the biological fate of chemicals.

Real-world pharmacogenetics of statin intolerance: effects of SLCO1B1, ABCG2, and CYP2C9 variants

M. Niemi, A. Tornio, A. Filppula, 2023, Pharmacogenetics and genomics.

Potent mechanism‐based inhibition of CYP3A4 by imatinib explains its liability to interact with CYP3A4 substrates

P. Neuvonen, J. Backman, P. Neuvonen, 2012, British journal of pharmacology.

Improved predictions of time-dependent drug-drug interactions by determination of cytosolic drug concentrations

P. Artursson, A. Mateus, P. Baranczewski, 2019, Scientific Reports.